| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.38 | 0.02 |